Know Cancer

or
forgot password

Expression of Met Receptor Fragments in Non Small Cell Lung Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Non Small Cell Lung Cancer

Thank you

Trial Information

Expression of Met Receptor Fragments in Non Small Cell Lung Cancer


Inclusion Criteria:



- Patients with non small cell lung cancer (NSCLC)

- Patients candidate for bronchial biopsies on Centre Oscar Lambret (metastatic stage)
or candidate for thoracic surgery on CHRU de Lille (localized stage)

- Chemo-naive for metastatic NSCLC

- Patients with or without induction chemotherapy for localized NSCLC

- Male or female subjects ≥ 18 years of age

- Ability to understand and willingness to sign a written Informed Consent

Exclusion Criteria:

- Non malignant tumors

- Small-cell malignancies

- Secondary malignant lesions

- Reversal surgery

- Pregnant or breastfeeding women

- Patient under guardianship

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Outcome Measure:

Evaluate the expression of Met C-terminal active fragments in NSCLC

Outcome Description:

Expression and localization of Met C-terminal active fragments in NSCLC(Western Blot and immunohistochemistry)

Outcome Time Frame:

baseline

Safety Issue:

No

Authority:

France: Committee for the Protection of Personnes

Study ID:

MetLung - 1204

NCT ID:

NCT01647867

Start Date:

July 2012

Completion Date:

July 2013

Related Keywords:

  • Non Small Cell Lung Cancer
  • non small cell lung cancer
  • Met fragments
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location